2021 ISAAI INTERESTING CASES & ANNUAL MEETING
The purpose of this activity is to provide allergists/immunologists an in depth and up to date approaches to asthma in context of GINA guidelines and to consider differential diagnoses for severe asthma.
In addition. there will be allergy/immunology case presentations from Rush University. Join us for great presentations and stimulating discussion.
Registration Fees
Attendee Type | Fee |
---|---|
ISAAI Member | FREE |
Speaker, Resident, or Fellow-in-Training | FREE |
Non-ISAAI Member | $60 |
Registration will remain open through 12:00 pm Central Time on Friday, January 29, 2021.
Credit claiming will open no later than 12:00 pm Central Time on Wednesday, February 3rd, and will remain open through 11:59 pm Central Time on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
Target Audience
- A/I Physicians
- Fellows-in-Training
- Nurse Practitioners
- Physician Assistants
Learning Objectives
Upon completion of this activity, participants should be able to:
- Understand how the guidelines support or change how allergists approach asthma.
- Consider other disease entities that are part of the differential diagnosis of severe asthma.
- Identify clinical findings or patient history information that would further clarify the immunodeficiency work up.
Additional Information
Attachment | Size |
---|---|
![]() | 9.83 KB |
Illinois Society of Allergy, Asthma & Immunology
Date: Sunday January 31th,2021
Place: Online Webinar: TBD
8:45-9:00 am
Business meeting
Reading of Nominees:
First & Second reading of applications
Moderator: Andrea Pappalardo,MD
9:00am-10:00 am
Robert Lemanske, MD
Updates on Asthma Guidelines
10:00-10:10 am
Break
10:10am-11:10 am
D. Kyle Hogarth, MD
Masqueraders of Severe Asthma
11:10-11:25 am
Break
11:25-12:25 pm
Interesting Cases from Rush University Medical Center
Ashley Ciliberti, MD
Young child presenting with new onset rash
Lauren Rigg, MD
Middle aged female presenting with facial angioedema
12:25 pm
Meeting Concludes
Planning Committee
Naveed Akhtar, MD
Advanced Allergy and Asthma Clinic, Bolingbrook, IL
Relevant relationships: None
Priya Bansal, MD FAAAAI
Asthma and Allergy Wellness Center, St. Charles, IL
Relevant relationships: None
Yasmeen Bilimoria, MD
Glen Allergy & Asthma
Relevant relationships, None
Christopher Codispoti, MD PhD FAAAAI
Rush University Medical Center, Chicago, IL
Relevant relationships: None
Katherine Conner, MD
Western Springs Asthma and Allergy, Western Springs, IL
Relevant relationships: None
Eugenia Hahn, MD FAAAAI
Advanced Allergy and Asthma Associates, Crystal Lake, IL
Relevant relationships: None
Jeffrey Kulik, MD
Elmhurst Clinic, Elmhurst, IL
Relevant relationships: None
Renee Lantner, MD FAAAAI
Western Springs Asthma and Allergy, Western Springs, IL
Relevant Relationships, None
Mahboobeh Mahdavinia, MD PhD FAAAAI
Rush University Medical Center, Chicago, IL
Relevant relationships: None
Sai Nimmagadda, MD FAAAAI
Pediatric Faculty Foundation, Chicago, IL
Relevant relationships: None
Andrea Pappalardo, MD FAAAAI
University of Illinois Hospital and Healthe Sciences Syste (UIC), Chicago, IL
Relevant relationships: None
Whitney Stevens
Northwestern University Feinberg School of Medicine
Relevant relationships, None
Faculty
Douglas K. Hogarth, CME
Univeristy of Chicago, Chicago, IL
Relevant relationships: None
Robert F. Lemanske, Jr., MD FAAAAI
University of Wisconsin School of Medicine and Public Health
Relevant relationships: None
Andrea A. Pappalardo, MD FAAAAI
University of Illinois Hospital & Health Sciences System, Chicago, IL
Relevant relationships: None
Fellow Faculty
Ashley Ciliberti, MD
Rush University Medical Center, Chicago, IL
Relevant relationships: None
Christopher D. Codispoti, MD PhD FAAAAI
Rush University Medical Center, Chicago, IL
Relevant relationships: None
Lauren Rigg, MD
Rush University Medical Center, Chicago, IL
Relevant relationships: None
Content Reviewer
Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Genentech: omalizumab for moderate-to-severe asthma; Pfizer: crisaborol for management of atopic dermatitis
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Illinois Society of Allergy, Asthma and Immunology. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm Central on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Available Credit
- 3.00 AttendanceAttendance credit.
- 3.00 CMECME credit.